高危子宫内膜癌盆腔前哨淋巴结检测(SHREC试验):手术分期范式转变的最后一步
这项前瞻性研究在高危子宫内膜癌(HREC)患者中评估盆腔前哨淋巴结(SLN)算法的诊断准确性。结论认为该算法可在有经验术者手中安全替代全淋巴结清扫。
要点
- SLN-ICG算法灵敏度98%,阴性预测值99.5%
- 总体SLN算法灵敏度及阴性预测值均达100%
- 双侧映射率95%,SLN操作无不良事件
核心结论
- 盆腔SLN算法对盆腔淋巴结转移达完全灵敏度,可在有经验术者手中排除总体淋巴结受累并安全替代全淋巴结清扫。
研究设计与样本
- 前瞻性研究,连续纳入 presumed FIGO I-II期高危子宫内膜癌女性,在两所学术中心由五位认证术者行机器人手术。
- 宫颈注射吲哚菁绿后遵循解剖学算法,预设淋巴通路未显示时重复注射示踪剂。
- 切除SLN后行盆腔及肾下腹主动脉旁淋巴结清扫,主要终点为SLN-ICG算法灵敏度。
主要发现
- 两例(一例ICG-SLN假阴性、一例未映射)的盆腔淋巴结转移由总体SLN算法识别。
- SLN-ICG算法灵敏度98%(95%CI 89-100),阴性预测值99.5%(95%CI 97-100)。
- 总体SLN算法灵敏度100%(95%CI 92-100),阴性预测值100%(95%CI 98-100)。
- 双侧映射率95%,两例(1%)有孤立腹主动脉旁转移,SLN操作期间无不良事件。
临床怎么用
- 在有经验术者手中,该盆腔SLN算法可安全替代高危子宫内膜癌的全淋巴结清扫。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY AIMS: To prospectively assess the diagnostic accuracy of a pelvic sentinel lymph node (SLN) algorithm in high-risk endometrial cancer (HREC). PATIENTS AND METHODS: Consecutive women with presumed FIGO stage I-II HREC underwent robotic surgery at two academic centres by five accredited surgeons. An anatomically based algorithm was adhered to, following cervical injection of indocyanine green (ICG), with reinjection of tracer in case of non-display of predefined lymphatic pathways. After removal of SLNs, a pelvic and infrarenal para-aortic lymphadenectomy was performed. Primary end-point was sensitivity of the SLN-ICG algorithm. Secondary end-points were sensitivity of the overall SLN algorithm (including macroscopically suspect nodes as SLNs), SLN mapping rates and morbidity of the SLN procedure. RESULTS: Two hundred fifty-seven women were analysed; 54 had pelvic lymph node metastases (LNMs), and 52 of those were correctly identified by the SLN-ICG algorithm. In two women (one with false-negative ICG-SLNs and one non-mapped woman), the pelvic LNMs were identified by the overall SLN algorithm. The SLN-ICG algorithm had a sensitivity of 98% (95% confidence interval [CI] 89-100) and a negative predictive value of 99.5% (95% CI 97-100). The sensitivity of the overall SLN algorithm was 100% (95% CI 92-100) and the negative predictive value was 100% (95% CI 98-100). The bilateral mapping rate was 95%. Two women (1%) had isolated para-aortic metastases. No adverse events occurred during the SLN procedure. CONCLUSION: With a complete sensitivity to detect pelvic LNMs, the described pelvic SLN algorithm can, in the hands of experienced surgeons, exclude overall nodal involvement in 99% and thereby safely replace a full lymphadenectomy in HREC.
引用
- Persson J, Salehi S, Bollino M, et al. Pelvic Sentinel lymph node detection in High-Risk Endometrial Cancer (SHREC-trial)-the final step towards a paradigm shift in surgical staging. Eur J Cancer. 2019. PMID: 31181536. doi:10.1016/j.ejca.2019.04.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。